JERRY TREPPEL

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

ELITE PHARMACEUTICALS INC /NV/

Filing Date Source Excerpt
2008-11-21 Jerry Treppel, Chairman of the Board and Director*
2009-09-08 Jerry Treppel has served as Chairman of the Board of Directors since November 2008 and a Director since October 2008. ... Mr. Treppel also serves as the Chair of Akorn’s Nominating and Corporate Governance Committee and as a member of its Audit Committee and Compensation Committee. ... The following table sets forth director compensation for the year ended March 31, 2009: Jerry Treppel Fees Paid or Earned in Cash ($) 8,750 Option Awards ($) 180,000 All Other Compensation ($) 8,333 Total ($) 17,083
2011-08-31 Mr. Treppel also served as Chairman of the Board since November 6, 2008 and CEO since September 15, 2009. Compensation due to Mr. Treppel is paid via the issuance of Common Stock, pursuant to the Company’s Director compensation policy. During Fiscal Year 2011, a total of 366,401 shares of Common Stock were issued to Mr. Treppel in satisfaction of Director’s fees totaling $22,500 earned during the year ended March 31, 2011. Mr. Treppel is owed an additional 136,845 shares of Common Stock in payment of Director’s fees totaling $7,500 due and owing for the three months ended March 31, 2011.
2014-04-03 Mr. Treppel has served as Chairman of the Board since November 6, 2008 and CEO from September 15, 2009 to July 31, 2013. Mr. Treppel stepped down from his position as Chief Executive Officer in August 2013 and is currently the Chairman of the Board of Directors. Director compensation table shows total compensation of $30,000.

Data sourced from SEC filings. Last updated: 2026-03-05